Jubi-R (Remdesivir) 100 mg

Indicated for the treatment of COVID-19 in adults and adolescents.

Usage Guidelines:

• 🏥 Hospital Setting: For patients with pneumonia requiring supplemental oxygen.
• ⏰ Timing is Key: Clinical data suggests highest efficacy when administered early (within the first 5-10 days of symptom onset) during the viral replication phase.

Form: Lyophilized powder for Injection (IV Infusion only).

⚠️ PROFESSIONAL ADMINISTRATION REQUIRED:

Standard Regimen:

• Day 1 (Loading Dose): 200 mg (2 vials) infused intravenously.
• Days 2–5 (Maintenance Dose): 100 mg (1 vial) once daily.

💉 Note: Must be reconstituted with sterile water and further diluted in 0.9% Saline solution before administration.

• Severe renal impairment (eGFR < 30 mL/min).
• Severe hepatic impairment (ALT > 5 times the upper limit of normal).
• Hypersensitivity to Remdesivir.

Monitoring is required during treatment:

• Liver Function: Elevated transaminase levels (ALT/AST). Daily blood tests are recommended.
• Infusion-related reactions: Nausea, hypotension, sweating, or shivering during administration.
• Allergic reactions (rare).